Table. Glaucoma Severity and Progression Risk Score and COVID-19 Morbidity Risk Score Point Valuesa.
| Characteristic | Points |
|---|---|
| Glaucoma severity and progression risk score | |
| Intraocular surgery within the past 3 mo | −25 |
| Monocularityb | −10 |
| More than 50% of recorded IOPs <6 mm Hg or >30 mm Hg in the past 12 mo | −10 |
| Mean deviation | |
| <−12 dB in both eyes | −10 |
| <−12 dB in 1 eye and ≥−12 dB in the contralateral eye | −5 |
| >−6 dB in both eyes | 10 |
| All IOPs in both eyes in the past 12 mo ≥6 mm Hg and ≤30 mm Hgc | 10 |
| COVID-19 risk score | |
| Pregnant or breastfeeding | 25 |
| Age, y | |
| ≥80 | 25 |
| 65-79 | 10 |
| Charlson Comorbidity Index | |
| >4 | 30 |
| 3-4 | 20 |
| 1-2 | 10 |
Abbreviation: IOP, intraocular pressure.
a
Point values assigned to each characteristic, for the glaucoma severity and progression risk score and the coronavirus disease 2019 morbidity risk score.
b
Defined as a best-recorded visual acuity score of 20/40 or better in 1 eye and 20/80 or worse in the contralateral eye.
c
A patient must have 1 or more IOP measurement recorded over the past 12 months to be eligible for this.